( click to enlarge )
Editas Medicine Inc (NASDAQ:EDIT) Coiling up here. Keep this one on your watch list. A break of $18.99 with force might give the stock room to $22.50. Indicators are looking bullish.
( click to enlarge )
Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) could be in the early stages of a technical breakout. If the stock can break through 3.30 tomorrow, I expect to see heavy volume drive the stock higher. Next major resistance lies around the 3.90 level.
( click to enlarge )
Onconova Therapeutics Inc (NASDAQ:ONTX) after basing sideways for at least four weeks, the stock broke out upwards today accompanied by a volume surge. Looks good for higher prices.
( click to enlarge )
Achaogen Inc (NASDAQ:AKAO) flagging for another move up. Breakout watch over 16.20
( click to enlarge )
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) on my watch-list a few times this month and today it broke out in impressive fashion on volume expansion. I believe the stock can easily re-visit the $4.5 level in the coming weeks, if not higher.~
( click to enlarge )
I continue to support the idea of a significant rally on shares of Trillium Therapeutics Inc. (NASDAQ:TRIL), probably even above the December highs. We still need to see a break and close above 6.20 to confirm a continuation to the upside with a next target in the 8 area. Good low float stock for current market enviroment.
( click to enlarge )
Opexa Therapeutics Inc (NASDAQ:OPXA) If the price can close above the 96c level this week, we might see some short covering.
( click to enlarge )
Biocept Inc (NASDAQ:BIOC) hit my scanner today with some impressive volume and closed up 77%. I expect some follow through on Wednesday.
If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
Labels: ADMP, AKAO, BIOC, DRNA, EDIT, ONTX, OPXA, TRIL